stockrowAprea Therapeutics, Inc. (APRE) vs Jaguar Animal Health, Inc. (JAGX)
- Aprea Therapeutics, Inc. APRE 0.43 −2.27%
- Jaguar Animal Health, Inc. JAGX 0.39 −2.50%
Aprea Therapeutics, Inc. and Jaguar Animal Health, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. is the larger, with a market value of $6.3M against $5.3M — 1.2× the size. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against −81.0%. Aprea Therapeutics, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 18 metrics below, Aprea Therapeutics, Inc. leads on 12 and Jaguar Animal Health, Inc. on 6.
Valuation
Profitability
| Metric | APRE | JAGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 82.31% | 68.27% |
| Operating margin | 0.00% | (93.10%) | 0.00% |
| Net margin | 0.00% | (188.46%) | 0.00% |
| Free cash flow margin | 0.00% | (24.03%) | 0.00% |
| Return on equity | (62.83%) | (1,125.38%) | (50.82%) |
| Return on assets | (53.24%) | (127.14%) | (46.08%) |
| Return on invested capital | 0.00% | (28,393.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack